Laurent Humeau - 04 Mar 2026 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Signature
/s/ Laurent Humeau
Issuer symbol
INO
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
05 Mar 2026, 16:55:40 UTC
Previous filing
27 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Humeau Laurent Chief Scientific Officer C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE RD., SAN DIEGO /s/ Laurent Humeau 05 Mar 2026 0001770390

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Option Award +26,840 $0.000000* 26,840 04 Mar 2026 Common Stock 26,840 $1.73 Direct F1
transaction INO Restricted Stock Unit Award +21,560 $0.000000* 21,560 04 Mar 2026 Common Stock 21,560 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting schedule for the 26,840 options granted on March 4, 2026 was as follows: 8,947 shares will vest on February 26, 2027; 8,947 shares will vest on February 26, 2028; 8,946 shares will vest on February 26, 2029.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.